Covaxin trials begin for children at AIIMS Patna

Earlier in the week, NITI Aayog's Member Health, Dr V.K. Paul said: "Covaxin has been approved by the Drugs Controller General of India (DCGI) for Phase 2 and 2 clinical trials in the age group of two to 18 years. I have been told that trials will begin in the next 10-12 days."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Rit3DN
via IFTTT